(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one

(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one is an organic compound with the molecular formula C11H16N2O2 and CAS number 92-13-7. This stereoisomerically defined molecule contains both an oxolane (tetrahydrofuran) ring and an imidazole moiety, giving it a molecular weight of 208.26 g/mol. It is classified as highly toxic and requires careful handling due to its acute toxicity properties.

(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one exhibits specific physicochemical characteristics determined by its heterocyclic structure containing both oxygen and nitrogen atoms. The compound has a molecular weight of 208.26 g/mol and molecular formula C11H16N2O2. The presence of the imidazole ring typically confers some degree of water solubility, while the oxolane ring and ethyl substituent contribute to its organic solvent compatibility. Detailed physical properties should be confirmed through technical documentation.

(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one serves as a specialized chemical intermediate in pharmaceutical and fine chemical synthesis. Its unique stereochemistry and functional groups make it valuable for developing complex organic molecules. The compound may be used in research applications, drug discovery programs, or as a building block for more complex pharmaceutical compounds. Its specific applications depend on the synthetic requirements and the target molecules being developed.

(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one requires strict safety measures due to its Acute Tox. 2 classification and GHS06 pictogram. Personnel must wear appropriate personal protective equipment including chemical-resistant gloves, safety goggles, and protective clothing. Work should be conducted in well-ventilated areas or under fume hoods to prevent inhalation exposure. Avoid skin contact, ingestion, and inhalation. Emergency procedures and safety data sheets should be readily available.

(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one must be stored in a secure, well-ventilated area away from incompatible materials. Due to its high toxicity classification, storage should be in a designated toxic substances area with restricted access. Containers should be tightly sealed and properly labeled. Storage temperature and conditions should follow manufacturer specifications. Keep away from heat sources, oxidizing agents, and incompatible chemicals to prevent degradation or dangerous reactions.

Immediate first aid measures are critical due to the compound's Acute Tox. 2 classification. For skin contact, remove contaminated clothing and wash affected area thoroughly with soap and water. In case of eye contact, flush immediately with water for at least 15 minutes. If inhaled, move person to fresh air immediately. For ingestion, do not induce vomiting and seek immediate medical attention. Contact poison control center and provide safety data sheet to medical personnel.

(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one requires disposal as hazardous waste due to its acute toxicity classification. Disposal must comply with local, national, and European waste regulations. The compound should be collected in appropriate containers and transferred to licensed hazardous waste disposal facilities. Never dispose of through regular waste streams or sewers. Incineration at authorized facilities may be required, following proper environmental protection protocols and obtaining necessary permits.

(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one is classified under ADR Class 6.1 (toxic substances), Packing Group II, indicating high toxicity during transport. Transportation requires appropriate UN-specification packaging, proper labeling with GHS06 pictogram, and compliance with dangerous goods regulations. Drivers must have ADR certification, and vehicles need appropriate placarding. Transport documents must include proper shipping names, hazard classes, and emergency response information. Only authorized carriers should handle this material.

(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one is subject to European chemical regulations including REACH and CLP. Under CLP, it carries Acute Tox. 2 classification with danger signal word and GHS06 pictogram. The compound is not currently listed as SVHC (Substance of Very High Concern). Users must comply with safety data sheet requirements, proper labeling, and workplace exposure limits. Registration under REACH may be required depending on quantities imported or manufactured.

(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one is available through OYSI, a specialized European distributor of technical chemicals. OYSI provides this compound to qualified industrial and research customers with proper handling capabilities for toxic materials. As a professional chemical supplier, OYSI ensures compliance with European regulations and provides necessary documentation including safety data sheets. Contact OYSI directly for availability, specifications, and purchasing requirements for this controlled substance.